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PREVALENCE OF ESBL-PRODUCING ENTEROBACTERIACEAE AMONG LEBANESE
PATIENTS WITH URINARY TRACT INFECTIONS
Abstract
Being the most common infections worldwide, Urinary Tract Infections (UTIs) represent a major public
health problem. Gram negative bacteria are the main pathogens causing UTIs where Extended spectrum
β–lactamase (ESBL)-Producing Enterobacteriaceae, mainly the multi-drug resistant species, such as E.
coli sequence type 131 and klebsiella.pneumoniae, account for serious health problems and high
economic burden. In Lebanon, data about prevalence of antibiotic resistant pathogens during UTIs are
still scarce. In this study we examined the prevalence of ESBL-producing pathogens among Lebanese
patients mainly located at Bekaa governorate. This retrospective study included 7241 urine tests that were
collected from all the out- and in-patients, presented to Rayak Hospital from 1-1-2019 till 31-12-2019.
Among the 7241 urine tests performed, 7.54% were positive. Among the positive samples, 59%, 17.5% and
1% were caused by E. coli, Klebsiella and Proteus, respectively. Other infections (22%) were caused by other
types of pathogens. Among the E. coli-positive samples, Klebsiella-positive samples and Proteus-positive
samples 45%, 26% and 17% were ESBL producing, respectively. The ESBL- producing pathogens
corresponded to 31% of the total positive UTIs. The distribution of these infection-causing pathogens
according to age, gender and hospitality condition was also determined. This study shows for the first
time the frequency and distribution of ESBL-producing pathogens among Lebanese UTI-patients in Bekaa
region.
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1. INTRODUCTION
Urinary tract infections (UTIs) represent the most common infections worldwide, among both
genders and both ambulatory and hospital admitted patients. In the united-states, UTIs are responsible
for more than 7 million physician visits annually (Susan M Schappert, 2011) and underlies 15% of all
community-prescribed antibiotics, with comparable phenomena in Europe (Susan M Schappert, 2011).
It is well established that nearly 1 in 3 women will have at least 1 episode of UTI requiring antimicrobial
therapy by the age of 24 years and almost half of all women will experience UTI during their lifetime.
The risk of UTI is higher in infants, pregnant women, and elderly patients. UTIs represent therefore a
major public health problem (de Kraker, Stewardson, & Harbarth, 2016) with a substantial economic
burden (de Kraker et al., 2016; Esteve-Palau et al., 2015; François et al., 2016; Susan M Schappert,
2011) due to their recurrence, the increasing hospitalization rate and the increasing prevalence of
antibiotic resistance among pathogens especially gram negative bacteria (Susan M Schappert, 2011).
Gram negative bacteria are the main pathogens causing UTIs with highest prevalence for E. coli that is
responsible for 70-95% of both upper and lower UTIs, followed by other gram negative
enteriobacteriacea such as klebsiella species and Proteus species (Mazzariol, Bazaj, & Cornaglia, 2017).
Antibiotics are vitally used to prevent and treat common infections, but their overuse and misuse have
contributed to an increase in antibiotic resistance. Anti-microbial resistance among UTI pathogens,
especially gram negative bacteria, has reached an alarming level posing challenges for choosing
effective antibiotics (Susan M Schappert, 2011). Extended spectrum β–lactamase (ESBL) are enzymes
that confer bacterial resistance to Penicillin; first-, second- and third-generation Cephalosporins and
Aztreonam; with no resistance to Cephamycins (as Cefoxitin) or Carbapenems (Bidell, Palchak, Mohr,
& Lodise, 2016). Hence, only few antibiotic options are available for treatment of ESBL producing
UTIs, which may require hospital admission or Intravenous administration of antibiotics in many case.
The prevalence of ESBLs is increasing worldwide (Mazzariol et al., 2017). ESBL outspread is
typically driven by international Multi-Drug Resistant (MDR) high-risk clones, mainly E. coli sequence
type 131 (ST131) and K. pneumoniae ST258 (Mazzariol et al., 2017). Besides their medical impact, the
economic burden of infections caused by ESBL-producing E. coli is high where an ESBL-producing
infection costs more than a non-ESBL-producing E. coli infection (de Kraker et al., 2016; Esteve-Palau
et al., 2015; François et al., 2016; Susan M Schappert, 2011; Vallejo-Torres et al., 2018). Looking at
hospital expenses separately, the total pharmacy costs and antibiotic costs of ESBL infections were
considerably higher than for non-ESBL infections, as was the need for outpatient parenteral antibiotic
therapy and its related costs (Susan M Schappert, 2011). In Lebanon, as in many other developing
countries, more than 30 % of antibiotics are dispensed without a prescription, and almost half of the
population self-medicates with antibiotics (Susan M Schappert, 2011) and despite the high prevalence
of antibiotic-resistance among pathogens, data in this regard remain scarce. The aim of this study was
therefore to assess the current status of ESBL producing pathogens among Lebanese patients mainly
located at Bekaa governorate.

2. METHODS
IRB approval for this study was received from the medical committee of Rayak hospital. This is
a retrospective study that was conducted at Rayak hospital laboratory department (situated in the Bekaa
governorate of Lebanon) from 1-1-2019 till 31-12-2019. The study included 7241 urine samples that
were collected from inpatients and outpatients that were performing urine cultures. Patients’
demographic data concerning age, gender and way of hospital admission were recorded.
Positive cultures yielding > 105 CFU/ml, were considered as positive. For positive cultures,
isolated bacteria, antibiotic resistance and sensitivity were tested. Urine cultures for bacterial isolation,
were carried out on Blood agar (enriched, bacterial growth medium) and Macconkey agar (selective and
differential for gram negative pathogens). Subcultures included chapman agar (selective medium for the
isolation of staphylococcus aureus), bile esculin agar (selective medium for streptococcus group D) and
sabouraud agar (selective for fungal growth). Differential tests were also used (urea, indol , oxydase ,
catalase ,coagulase, API strep). Anti-microbial susceptibility testing and interpretations were determined
using two methods: disc diffusion method on Muller Hinton agar (by following the instructions of the
ministry of public health) and the VITEK 2 system (BIOMERIEUX ,france). The following antibiotic
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disks were used: Ampicillin (10 μg) ; Amoxicillin/Clavulanic acid (20/10 μg) ; Piperacillin/tazobactam
(100/10 μg) ; Cefuroxime (30 μg) ; Cefepime (30 μg); Cefoxitin (30 μg) ; Cefotaxime (30 μg) ;
Ceftazidime (30 μg) ; Cefixime (5 μg) ; Imipenem (10 μg) ; Gentamicin (10 μg) ; Amikacin (30 μg) ;
Ciprofloxacin (5 μg) ; Trimethroprim-sulfamethoxazole (1,25-23.75 μg) ; Nitrofurantoin (300 μg) ;
Aztreonam (30 μg) ; Ertapenem (10 μg) ; Fosfomycin+ (200 μg) ; Tigecycline (15 μg) ; Tetracycline
(30 μg). In suspected ESBL isolates, we examined the main antibiotics before reporting. It should be
showing R or I for Aztreonam, Ceftazidime, Cefotaxime, and/or Ceftriaxone On the other hand, it shows
S to Cefoxitin and Imipenem, irrespective of the remaining antibiotics. This has been validated and
reflects a cost effective and accurate method in the determination of ESBL.
For the statistical analysis, we reported percentages, means, and frequencies. Data were processed
using SPSS program (version 23).

3. RESULTS
This study included 7241 urine tests that were collected from all the out- and in-patients, presented
to Rayak Hospital from 1-1-2019 till 31-12-2019. Among those: 3561 (49%) were females and 3680
(51%) were males; 6342 (87.5%) were in-patients, 796 (11%) were out-patients, whereas 103 (1.5%)
were in the Emergency department (ER) (as shown as Fig.1). Those patients belonged to different age
groups: (0-20 years) (1824; 26%), (21-40 years) (865; 12%), (41-60 years) (1610; 22%), (61-80 years)
(1978; 27%), (81-100 years) (964; 13%) (as shown as Fig. 1).

Fig.1: Distribution of the patients who performed urine test according to their age range, sex and hospitality
condition.
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Among the total 7241 urine tests performed, 546 (7.54%) tests were positive (as shown as Fig.
2). Out of the 546 positive urine cultures, 395 (72.3%) belonged to females patients whereas 151 (27.7%)
belonged to male patients. Those positively diagnosed patients corresponded to 378 (69%) in-patients,
139 (25.5%) out-patients and 29 (5.5%) ER-patients (as shown as Fig. 2). Those patients were
distributed among different age groups: (0-20 years) (124; 22.7%), (21-40 years) (82; 15%), (41-60
years) (65; 12%), (61-80 years) (174; 32%), (81-100 years) (100; 18.3%) (as shown as Fig. 2).

Fig.2: Distribution of the UTI-positive patients according to their age ranges, sex and hospitality
condition.

Among the 546 positive urine infections, 322 (59%) were caused by E. coli, 96 (17.5%) were
caused by Klebsiella and 6 (1%) were caused by Proteus where the other samples 122 (22%) were
caused by other types of pathogens such as pseudomonas, enterobacter, enterococci, staphylococcus
and candida (as shown as Fig.
3).
Among the 322 E. coli-positive samples, 165 (51%) contained non-ESBL E. coli, 144 (45%)
contained ESBL producing E. coli whereas 13 (4 %) contained CRE E. coli (as shown as Fig. 3). Among
the 96 Klebsiella-positive samples, 66 (69%) contained non-ESBL Klebsiella, 25 (26%) contained
ESBL producing Klebsiella whereas 5 (5 %) contained CRE Klebsiella as shown as Fig. 3). Among the
6 Proteus -positive samples, 5 (83%) contained non-ESBL
Proteus where only 1 (17%) contained
ESBL producing Proteus (as shown as Fig. 3).
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Fig.3: Distribution of E. coli, Klebsiella, Proteus and other pathogens among the UTI patients.
It is noteworthy that among the 546 positive urine infections, 170 samples (31%) contained
ESBL- producing pathogens. Among the 170 detected ESBL pathogens, 144 (84.7%) were E. coli, 25
(14.7%) were Klebsiella species (pneumonie and ocytoca) and 1 (0.6%) were Proteus (as indicated in
Table 1). Among the whole sample, the incidence of ESBL producing gram negative enterobactriaceae
according to gender corresponded to 123/395 samples (31.12%) in females and 47/151 samples (27,
65%) in males. The highest incidence according to age groups was found in the age groups 0-20 years
and 61-80 years, with 45/124 (36,2%) and 55/174 (31,6%), respectively. ESBL-producing pathogens
incidence corresponded to 120/407 (29,4 %) among inpatients and 40/139 (28.7%) among all
outpatients.
Table 1: Frequencies and Percentages of the detected ESBL producing bacteria.

ESBL-producing Bacteria

Numbers

Percentages

E.coli (ESBL)

144

84.7%

Klebsiella (ESBL)

25

14.7%

Proteus (ESBL)

1

0.6%

170

100%

Total
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4. DISCUSSION
Urinary Tract Infections correspond to the most common bacterial infections among out-and inpatients, therefore represent a major health issue of modern medicine. Misuse and overuse of antibiotics
have complicated further the issue leading to the highest rates of resistance among urinary pathogens,
thus rendering patients’ health at high risk, along with the substantial treatment costs.
Our study focused on assessing the prevalence of ESB-producing enterobacteriacea among
hospital and community acquired UTIs, reported at Rayak hospital from 1-1-2019 till 31-12-2019 with
distribution based on demographic variants and type of admission.
In the present study, out of 546 identified positive urine cultures, E.coli was the predominant 59%,
followed by klebsiella 17,5%, and proteus 1%. On the other hand, other pathogens (including as
pseudomonas, enterobacter, enterococci, staphylococcus, and candida) represented 22%. Notably, the
output of this study is consistent with the results of a previous study done in the south of Lebanon in
2017 (Sokhn et al., 2020) where the prevalence of E.coli, klebsiella, proteus and other pathogens among
UTIs was 67,1%, 10%, 3.7% and 19,2 % respectively (Sokhn et al., 2020). Moreover, this prevalence is
comparable to that observed in other studies done in different geographic regions (Ahmed et al., 2015;
Chamoun et al., 2016; Morrissey et al., 2013; Pasillas Fabian et al., 2021).
It is well known that females have the highest incidence rate among positive urine cultures. This
can be explained by the cross infection during sexual intercourse, and by the female anatomy
characterized by a short urethra, and the short distance between the opening of the urethra and those of
the anus and vagina as well as the spermicidal use in young females (Raz et al., 2000). Moreover,
decrease of estrogen level, urodynamic factors especially incontinence, non-secretor status and other
factors make post-menopausal women more vulnerable to infection. Consistently, in this study we
observed that 72,3% of the positive UTIs belonged to females. In addition to the sex distribution,
different age groups were affected by bacterial pathogens but the prevalence was the highest in age
groups 0-20 years and
61-80 years representing 26% and 27 %, respectively.
Among the positively diagnosed UTIs, 170/546 (31%) contained ESBL-producing
enterobatriacea. Among the detected ESBL-producing enterobatriacea, 84.7% were E. coli which
constitute 26.37 % of the total reported UTIs On the other hand, 14.7% were Klebsiella species
representing 4.57% of the total UTIs and 0.6% were Proteus corresponding to 0,18 % of the total UTIs.
The results of this study were consistent with the Study for Monitoring Antimicrobial Resistance Trends
(SMART) which evaluated the prevalence of ESBL production among enterobacteriacea (E. coli,
klebsiella and proteus) isolated from UTIs between 2009 and 2011, and reported highest prevalence in
Asia and Middle east with significant increase from 2009 till 2011 (Middle east p<0,001 and Asia
p=0,002) and a lower prevalence in Europe 20% (Morrissey et al., 2013). Besides, a previous study done
in south Lebanon in 2017 showed very similar results with 32,9% prevalence of ESBL producers among
enterobacteriaceae where E. coli was the major ESBL producer with 35,2 % among total E. coli isolates
and 27,7% ESBL producing klebsiella among klebsiella isolates (Sokhn et al., 2020). Moreover, a
previous study done at Pakistan institute of medical sciences in 2015 confirmed the increasing trend of
ESBL production, where ESBL-producing E. coli and ESBL-producing klebsiella represented 35.5 %
and 2,93 % of the total UTIs, respectively (Ahmed et al., 2015). High rates of ESBL production among
gram negative pathogens, were also reported in Saudi Arabia (33%) (Alqasim, Abu Jaffal, & Alyousef,
2018), in India where ESBL-producing E. coli represented 69% of E. coli and 41% of klebsiella species
isolates were ESBL producers . Furthermore, a study carried out among UTIs in turkey showed that
66.2% E. coli and 64.4% K. pneumonia were ESBL-producers (Moges et al., 2019). Lower rates were
reported in Danish (Hansen et al., 2012) and Canada (Simner et al., 2011) where ESBL production was
2.4 % and 5%, respectively. This could be due to the appropriate measures concerning antibiotic
prescription and infections control in these advanced countries.
In our present study, incidence of ESBL producing pathogens was similar between outpatients
and hospital admitted patients with 28,7% and 29,4 % respectively; similar between males and females
with 31,12% and 31,13% respectively but with highest incidence in the age groups 0-20 years and 6180 years with 36,2 % and 31,6 %, respectively. The results of this study are in line with a previous study
in Lebanon that reported that ESBL production occurs almost equally between in-patients (51,1%) and
out-patients(48,9%) (Sokhn et al., 2020). These results confirm that multi drug resistance which is
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increasing among community patients and affecting children in an ascending
pattern, constitutes
an alarming concern that needs immediate control measures.
One limitation in this study corresponds the lack of molecular tests for the identification and
confirmation of ESBL producing-strains. Another limitation is the absence of assessment of other risk
factors for UTIs, including diabetes, prostate hypertrophy, sexually transmitted diseases (STDs),
immune-suppression, foley catheter, and kidney stones.

5.

CONCLUSION
This study revealed the predominance of E. coli among pathogens responsible of UTIs in
Lebanese population with increasing incidence of ESBL producing enterobacteriaceae among both
hospital-admitted and outpatients. These results are alarming since the increasing prevalence of MDR
Enterobacteriaceae limits the available options for treatment of UTIs. It is therefore strongly
recommended to prescribe antibiotics based on positive urine culture and antibiogram results with
control of the Minimum Inhibitory Concentration (MIC). Proper counseling of patients should be
necessary to monitor their compliance to proper and complete courses of medications, which can limit
the evolution of resistant strains.
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